Who is sponsoring BCGR?

BCGR is sponsored by Bandim Health Project.

What condition does BCGR study?

BCGR studies Infant Mortality, BCG.

What drugs are being tested in BCGR?

Interventions: BCG-Denmark 1331 (Statens Serum Institute).

Last reviewed 2022-02-03 · How we verify

Can Earlier BCG Vaccination Reduce Early Infant Mortality? A Randomised Trial (BCGR)

NCT02504203 Phase 4 TERMINATED

The purpose of this study is to determine whether BCG vaccination shortly after birth can reduce early infant mortality in a rural and an urban setting.

Details

Lead sponsor	Bandim Health Project
Phase	Phase 4
Status	TERMINATED
Enrolment	2332
Start date	2015-11
Completion	2021-06

Conditions

Infant Mortality
BCG

Interventions

BCG-Denmark 1331 (Statens Serum Institute)

Primary outcomes

Non-accidental mortality — 60 days after birth
Non-accidental mortality between the home visit and the next follow-up visit by BHP, when all unvaccinated children who are home will be offered BCG or the date of registering a non-trial vaccine or 60 days, whichever comes first.

Countries

Guinea-Bissau